Aditxt (ADTX) Competitors $0.33 -0.01 (-2.63%) (As of 01:45 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ADTX vs. ONVO, HURA, BMRA, AEZS, UPXI, APVO, CYCN, ALZN, BNOX, and HEPAShould you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include Organovo (ONVO), TuHURA Biosciences (HURA), Biomerica (BMRA), Aeterna Zentaris (AEZS), Upexi (UPXI), Aptevo Therapeutics (APVO), Cyclerion Therapeutics (CYCN), Alzamend Neuro (ALZN), Bionomics (BNOX), and Hepion Pharmaceuticals (HEPA). These companies are all part of the "pharmaceutical products" industry. Aditxt vs. Organovo TuHURA Biosciences Biomerica Aeterna Zentaris Upexi Aptevo Therapeutics Cyclerion Therapeutics Alzamend Neuro Bionomics Hepion Pharmaceuticals Aditxt (NASDAQ:ADTX) and Organovo (NASDAQ:ONVO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation. Which has stronger earnings and valuation, ADTX or ONVO? Organovo has lower revenue, but higher earnings than Aditxt. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAditxt$640K2.18-$32.38MN/AN/AOrganovo$110K49.60-$14.67M-$1.06-0.33 Do insiders and institutionals believe in ADTX or ONVO? 15.5% of Aditxt shares are held by institutional investors. Comparatively, 8.2% of Organovo shares are held by institutional investors. 1.7% of Aditxt shares are held by company insiders. Comparatively, 3.7% of Organovo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to ADTX or ONVO? In the previous week, Aditxt had 1 more articles in the media than Organovo. MarketBeat recorded 3 mentions for Aditxt and 2 mentions for Organovo. Organovo's average media sentiment score of 0.80 beat Aditxt's score of 0.61 indicating that Organovo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aditxt 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Organovo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ADTX or ONVO more profitable? Aditxt has a net margin of 0.00% compared to Organovo's net margin of -12,176.70%. Organovo's return on equity of -249.28% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets AditxtN/A -439.07% -122.96% Organovo -12,176.70%-249.28%-159.50% Does the MarketBeat Community prefer ADTX or ONVO? Organovo received 192 more outperform votes than Aditxt when rated by MarketBeat users. Likewise, 47.80% of users gave Organovo an outperform vote while only 44.44% of users gave Aditxt an outperform vote. CompanyUnderperformOutperformAditxtOutperform Votes444.44% Underperform Votes555.56% OrganovoOutperform Votes19647.80% Underperform Votes21452.20% Which has more risk and volatility, ADTX or ONVO? Aditxt has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Organovo has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. SummaryOrganovo beats Aditxt on 7 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADTX vs. The Competition Export to ExcelMetricAditxtPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.43M$6.45B$5.04B$8.81BDividend YieldN/A8.11%5.16%4.07%P/E RatioN/A10.78130.5317.82Price / Sales2.23243.701,183.8674.55Price / CashN/A22.1633.6132.53Price / Book0.005.474.684.68Net Income-$32.38M$153.61M$119.23M$226.08M7 Day Performance-2.75%-2.00%-1.83%-1.04%1 Month Performance-68.91%-7.46%-3.61%1.04%1 Year Performance-99.76%31.82%31.74%26.28% Aditxt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADTXAditxt0.4823 of 5 stars$0.33-2.6%N/A-99.8%$1.39M$640,000.000.0047ONVOOrganovo0.6793 of 5 stars$0.36+1.4%N/A-72.7%$5.46M$110,000.00-0.3320Analyst ForecastNews CoverageHURATuHURA Biosciences0.9613 of 5 stars$3.39+3.0%$15.00+342.5%N/A$5.39MN/A0.00N/ANegative NewsGap UpBMRABiomerica0.2078 of 5 stars$0.32-1.3%N/A-64.4%$5.38M$5.41M-0.8860News CoverageGap DownAEZSAeterna ZentarisN/A$2.98-0.7%N/A-57.4%$5.35M$2.37M-0.2020UPXIUpexi1.4452 of 5 stars$4.96+12.7%$25.00+404.0%-78.0%$5.16M$80.68M0.00130APVOAptevo Therapeutics2.0864 of 5 stars$0.28-5.2%$8.00+2,809.1%-96.7%$5.09M$3.11M0.0050Gap DownCYCNCyclerion Therapeutics0.9907 of 5 stars$1.87-10.5%N/A-7.7%$5.07M$1.62M0.0030Gap DownHigh Trading VolumeALZNAlzamend Neuro1.9277 of 5 stars$1.30-0.8%$35.00+2,592.3%-90.6%$5.06MN/A0.004BNOXBionomics2.6054 of 5 stars$0.28+0.9%$8.00+2,710.0%-86.1%$4.93M$10,000.000.00N/AGap UpHEPAHepion PharmaceuticalsN/A$0.69-0.6%N/A-78.1%$4.80MN/A0.0020 Related Companies and Tools Related Companies Organovo Alternatives TuHURA Biosciences Alternatives Biomerica Alternatives Aeterna Zentaris Alternatives Upexi Alternatives Aptevo Therapeutics Alternatives Cyclerion Therapeutics Alternatives Alzamend Neuro Alternatives Bionomics Alternatives Hepion Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADTX Stock Alerts